• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肥大细胞瘤犬的氧化状态和脂质代谢分析物:一项初步研究。

Oxidative Status and Lipid Metabolism Analytes in Dogs with Mast Cell Tumors: A Preliminary Study.

作者信息

Ginoudis Argyrios, Pardali Dimitra, Mylonakis Mathios E, Tamvakis Androniki, Tvarijonaviciute Asta, Lymperaki Evgenia, Ceron Jose Joaquin, Polizopoulou Zoe

机构信息

Diagnostic Laboratory, School of Veterinary Medicine, Faculty of Health Sciences, Aristotle University of Thessaloniki, 546 27 Thessaloniki, Greece.

Companion Animal Clinic, School of Veterinary Medicine, Faculty of Health Sciences, Aristotle University of Thessaloniki, 546 27 Thessaloniki, Greece.

出版信息

Antioxidants (Basel). 2024 Nov 29;13(12):1473. doi: 10.3390/antiox13121473.

DOI:10.3390/antiox13121473
PMID:39765802
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11672985/
Abstract

Mast cell tumors (MCTs) are common skin neoplasms in dogs. Prognostic indicators include histologic grade, clinical stage, high Ki-67 index, elevated argyrophilic nucleolus organizer regions (AgNOR) index, mutations, and recurrence after surgery. Blood serum redox status has been shown to correlate with prognostic factors in canine lymphoma and mammary tumors. This study aimed to assess the correlation between established prognostic factors and serum redox status and lipid metabolism analytes in dogs with MCTs. Dogs with cutaneous ( = 33) or subcutaneous ( = 6) MCTs, without comorbidities, were studied. Staging was evaluated based on cytology of regional lymph nodes and ultrasound-guided liver and spleen aspiration cytology. Histologic grading and immunohistochemical staining for Ki-67 and KIT patterns were performed on excised tumor specimens. Dogs were categorized by Patnaik grading (1-3), Kiupel grading (low/high), metastatic status, Ki-67 positive nuclei per cm (>23 or ≤23), and KIT pattern (I, II-III). Paraoxonase-1, Butyrylcholinesterase, Cupric Reducing Antioxidant Capacity (CUPRAC), Diacron Reactive Oxygen Metabolites (d-ROMs), and oxy-adsorbent levels were measured before any therapeutic intervention. ANOVA and independent -tests were used to detect differences in the mean values among groups. Paraoxonase-1 activity was significantly lower in Patnaik grade 3 ( = 0.003) and Kiupel high-grade ( = 0.022) MCTs. No significant differences were found in CUPRAC, d-ROMs, or oxy-adsorbent levels across different prognostic groups. This study found a significant correlation between histologic grading and Paraoxonase-1 activity, suggesting a potential role of Paraoxonase-1 as a prognostic biomarker in canine MCTs.

摘要

肥大细胞瘤(MCTs)是犬类常见的皮肤肿瘤。预后指标包括组织学分级、临床分期、高Ki-67指数、嗜银核仁组织区(AgNOR)指数升高、突变以及术后复发。血清氧化还原状态已被证明与犬淋巴瘤和乳腺肿瘤的预后因素相关。本研究旨在评估已确定的预后因素与患有MCTs的犬血清氧化还原状态和脂质代谢分析物之间的相关性。对患有皮肤(n = 33)或皮下(n = 6)MCTs且无合并症的犬进行了研究。基于区域淋巴结的细胞学检查以及超声引导下肝脏和脾脏穿刺细胞学检查进行分期评估。对切除的肿瘤标本进行组织学分级以及Ki-67和KIT模式的免疫组织化学染色。根据帕特奈克分级(1 - 3级)、基佩尔分级(低/高)、转移状态、每平方厘米Ki-67阳性核数(>23或≤23)以及KIT模式(I、II - III)对犬进行分类。在任何治疗干预之前测量对氧磷酶-1、丁酰胆碱酯酶、铜还原抗氧化能力(CUPRAC)、戴克隆活性氧代谢物(d-ROMs)和氧吸附剂水平。使用方差分析和独立t检验来检测各组平均值之间的差异。对氧磷酶-1活性在帕特奈克3级(P = 0.003)和基佩尔高级别(P = 0.022)MCTs中显著降低。在不同预后组的CUPRAC、d-ROMs或氧吸附剂水平上未发现显著差异。本研究发现组织学分级与对氧磷酶-1活性之间存在显著相关性,表明对氧磷酶-1作为犬MCTs预后生物标志物具有潜在作用。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1d1a/11672985/d83c0fce54a0/antioxidants-13-01473-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1d1a/11672985/bc6ba77bde13/antioxidants-13-01473-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1d1a/11672985/d83c0fce54a0/antioxidants-13-01473-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1d1a/11672985/bc6ba77bde13/antioxidants-13-01473-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1d1a/11672985/d83c0fce54a0/antioxidants-13-01473-g002.jpg

相似文献

1
Oxidative Status and Lipid Metabolism Analytes in Dogs with Mast Cell Tumors: A Preliminary Study.肥大细胞瘤犬的氧化状态和脂质代谢分析物:一项初步研究。
Antioxidants (Basel). 2024 Nov 29;13(12):1473. doi: 10.3390/antiox13121473.
2
Comparison of 2- and 3-category histologic grading systems for predicting the presence of metastasis at the time of initial evaluation in dogs with cutaneous mast cell tumors: 386 cases (2009-2014).2类和3类组织学分级系统对犬皮肤肥大细胞瘤初次评估时转移情况预测能力的比较:386例病例(2009 - 2014年)
J Am Vet Med Assoc. 2015 Apr 1;246(7):765-9. doi: 10.2460/javma.246.7.765.
3
Canine mast cell tumors: correlation of apoptosis and proliferation markers with prognosis.犬肥大细胞瘤:凋亡和增殖标志物与预后的相关性
J Vet Intern Med. 2006 Jan-Feb;20(1):151-8. doi: 10.1892/0891-6640(2006)20[151:cmctco]2.0.co;2.
4
Validation of the prognostic value of histopathological grading or c-kit mutation in canine cutaneous mast cell tumours: a retrospective cohort study.验证组织病理学分级或 c-kit 突变在犬皮肤肥大细胞瘤预后中的价值:一项回顾性队列研究。
Vet J. 2013 Jun;196(3):492-8. doi: 10.1016/j.tvjl.2012.11.018. Epub 2013 Feb 4.
5
Analysis of risk factors for canine mast cell tumors based on the Kiupel and Patnaik grading system among dogs with skin tumors.基于 Kiupel 和 Patnaik 分级系统分析皮肤肿瘤犬的肥大细胞瘤的风险因素。
Open Vet J. 2021 Oct-Dec;11(4):619-634. doi: 10.5455/OVJ.2021.v11.i4.12. Epub 2021 Nov 11.
6
Histologic grading of canine mast cell tumor: is 2 better than 3?犬肥大细胞瘤的组织学分级:二级优于三级吗?
Vet Pathol. 2015 Jan;52(1):70-3. doi: 10.1177/0300985814521638. Epub 2014 Feb 10.
7
Expression of Ki67, BCL-2, and COX-2 in canine cutaneous mast cell tumors: association with grading and prognosis.Ki67、BCL-2 和 COX-2 在犬皮肤肥大细胞瘤中的表达:与分级和预后的关系。
Vet Pathol. 2013 Jan;50(1):110-21. doi: 10.1177/0300985812447829. Epub 2012 Jun 6.
8
Mutations in Exons 8 and 11 of Gene in Canine Subcutaneous Mast Cell Tumors and Their Association with Cell Proliferation.犬皮下肥大细胞瘤中基因外显子8和11的突变及其与细胞增殖的关系
Vet Sci. 2022 Sep 10;9(9):493. doi: 10.3390/vetsci9090493.
9
The use of KIT and tryptase expression patterns as prognostic tools for canine cutaneous mast cell tumors.将KIT和类胰蛋白酶表达模式用作犬皮肤肥大细胞瘤预后工具的研究
Vet Pathol. 2004 Jul;41(4):371-7. doi: 10.1354/vp.41-4-371.
10
Prevalence of exon 11 internal tandem duplications in the C-KIT proto-oncogene in Australian canine mast cell tumours.澳大利亚犬肥大细胞瘤中C-KIT原癌基因第11外显子内部串联重复的患病率。
Aust Vet J. 2017 Oct;95(10):386-391. doi: 10.1111/avj.12636.

本文引用的文献

1
Preoperative BChE serves as a prognostic marker in patients with resectable AEG after neoadjuvant chemotherapy.术前 BChE 可作为新辅助化疗后可切除 AEG 患者的预后标志物。
Langenbecks Arch Surg. 2023 Jun 6;408(1):227. doi: 10.1007/s00423-023-02938-w.
2
The Importance of Thioredoxin-1 in Health and Disease.硫氧还蛋白-1在健康与疾病中的重要性
Antioxidants (Basel). 2023 May 11;12(5):1078. doi: 10.3390/antiox12051078.
3
Paraoxonase 1 and atherosclerosis.对氧磷酶1与动脉粥样硬化
Front Cardiovasc Med. 2023 Feb 16;10:1065967. doi: 10.3389/fcvm.2023.1065967. eCollection 2023.
4
BCHE as a Prognostic Biomarker in Endometrial Cancer and Its Correlation with Immunity.BCHE 作为子宫内膜癌的预后生物标志物及其与免疫的相关性。
J Immunol Res. 2022 Jul 21;2022:6051092. doi: 10.1155/2022/6051092. eCollection 2022.
5
Changes in the Oxidative Stress Status of Dogs Affected by Acute Enteropathies.患急性肠病犬的氧化应激状态变化
Vet Sci. 2022 Jun 6;9(6):276. doi: 10.3390/vetsci9060276.
6
The Relationship between Cancer and Paraoxonase 1.癌症与对氧磷酶1之间的关系
Antioxidants (Basel). 2022 Mar 31;11(4):697. doi: 10.3390/antiox11040697.
7
Diagnosis, Prognosis and Treatment of Canine Cutaneous and Subcutaneous Mast Cell Tumors.犬皮肤和皮下肥大细胞瘤的诊断、预后和治疗。
Cells. 2022 Feb 10;11(4):618. doi: 10.3390/cells11040618.
8
Serum oxidative stress is an independent prognostic marker in colorectal cancer.血清氧化应激是结直肠癌的一个独立预后标志物。
Transl Cancer Res. 2019 Sep;8(5):1699-1708. doi: 10.21037/tcr.2019.08.15.
9
Effects of Greek Honey and Propolis on Oxidative Stress and Biochemical Parameters in Regular Blood Donors.希腊蜂蜜和蜂胶对定期献血者氧化应激及生化指标的影响
J Xenobiot. 2022 Jan 4;12(1):13-20. doi: 10.3390/jox12010002.
10
Inflammation and its association with oxidative stress in dogs with heart failure.心力衰竭犬的炎症及其与氧化应激的关系。
BMC Vet Res. 2021 Apr 26;17(1):176. doi: 10.1186/s12917-021-02878-x.